Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001836740-23-000001
Filing Date
2023-02-13
Accepted
2023-02-10 17:47:52
Documents
1
Effectiveness Date
2023-02-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12524
  Complete submission text file 0001836740-23-000001.txt   13590
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 617-475-8493
Avilar Therapeutics, Inc. (Filer) CIK: 0001836740 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-383553 | Film No.: 23613760